Pre-Treatment MMP7 Predicts Progressive Idiopathic Pulmonary Fibrosis in Antifibrotic Treated Patients

CONCLUSION: MMP7 along with a multi-biomarker and GAP panel can predict IPF progression and mortality, with the potential for optimising …